| 000 | 01149nam a22001697a 4500 | ||
|---|---|---|---|
| 005 | 20241011100313.0 | ||
| 008 | 241011b ph ||||| |||| 00| 0 eng d | ||
| 040 | _cOCT | ||
| 100 | _aKverno, Karan | ||
| 240 |
_aJournal of Psychosocial Nursing and Mental Health Services / _hNovember 2022 |
||
| 245 |
_aDextromethorphan : _bFrom cough suppressant to antidepressant / _cKaran Kverno |
||
| 300 |
_aVol 60 (11) pages 9-11 : _billustrations ; _c27 cm |
||
| 500 | _aABSTRACT Dextromethorphan (DXM) has been repurposed several times over the past 7 decades: first as a cough suppressant, then as a compounded formulation with quinidine for treatment of pseu-dobulbar affect, and most recently as a compounded formulation with bupropion for treatment of major depressive disorder. The current article describes the history and purported mechanisms of action of DXM for each use and the uniquely rapid action and safety profile of the oral dextromethorphan-bupropion antidepressant formulation. [Journal of Psychosocial Nursing and Mental Health Services, 60(11), 9-11.] | ||
| 653 | _aCough suppressant | ||
| 653 | _aAntidepressant | ||
| 942 |
_2ddc _cCR _n0 |
||
| 999 |
_c9763 _d9763 |
||